DIANA POLANIA: Open Payments
NPI 1740050111 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $405 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $386 |
| VIVUS LLC | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Ardelyx, Inc. | 2 | $38 |
| Intercept Pharmaceuticals, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Novo Nordisk Inc | 1 | $21 |
| QOL Medical, LLC | 1 | $15 |
Products named: REZDIFFRA, IBSRELA, QSYMIA, EOHILIA, OCALIVA, VOQUEZNA, Wegovy, PANCREAZE.
Industry payments across NJ — which companies pay providers there.
